Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 60Active not recruiting 8Terminated 6Withdrawn 5Recruiting 4Unknown 3No longer available 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 2Advanced Prostate Cancer 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × radium Ra 223 dichloride × Clear all
NCT03458559 2020-11-17

RaRe

Amsterdam UMC, location VUmc

Phase 3 Unknown
402 enrolled
Genitourinary

Prostatic Neoplasms

NCT02925702 2020-01-27

PRORADIUM

Centro Nacional de Investigaciones Oncologicas CARLOS III

Unknown
161 enrolled
Genitourinary

Advanced Prostate Cancer

NCT02484339 2016-04-27

α-RT

University Hospital Freiburg

Phase 2 Unknown
274 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡